Through the episode, the trio highlights the advantages of using in-house tests, how rapid titer testing enables personalized ...

State officials have confirmed 14 new measles cases tied to the Upstate, with more possible exposures tied to Spartanburg ...

U.S. flu rates remain low, but experts are keeping an eye on a new strain that’s been linked to unexpectedly early and severe ...

Influenza is picking up in the U.S., and public health experts are bracing for signs of another brutal season with the virus.

University of Pennsylvania researchers say their findings could potentially lead to the development of a blood test to monitor people at high risk of developing Type 1 diabetes. New research into ...

While mRNA vaccines trigger potent initial immune responses, emerging data suggest they do not generate durable plasma cells, ...

If you’re the kind of person who would 100% turn around on a one-way ticket if someone said “you can’t bring your... The post Countries Where Bringing Your Pet Is (Relatively) Easy appeared first on ...

This valuable study addresses a critical and timely question regarding the role of a subpopulation of cortical interneurons (Chrna2-expressing Martinotti cells) in motor learning and cortical dynamics ...

In this free webinar, learn about an alternative automated immunoassay technology and how it performs compared to traditional ELISA. Attendees will discover how the features of an automated ...

A 42-year-old man presented to the emergency department with complaints of difficulty ambulating, fatigue, unintentional weight loss and progressively worsening near vision.His medical history was ...

Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved dosing in Cohort 8 of ENDEAVOR ...